A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot study

OBJECTIVE: We aimed at comparing clinical/immunological outcomes in human immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and conventional efavirenz (EFV) therapy. METHODS: This study was a 24-week prospective randomized controlled trial. Eligible patients were HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Damronglerd, Pansachee, Sukasem, Chonlaphat, Thipmontree, Wilawan, Puangpetch, Apichaya, Kiertiburanakul, Sasisopin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638311/
https://www.ncbi.nlm.nih.gov/pubmed/26622191
http://dx.doi.org/10.2147/PGPM.S86446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638311/
https://www.ncbi.nlm.nih.gov/pubmed/26622191
http://dx.doi.org/10.2147/PGPM.S86446

Ejemplares similares